ABSTRACr The concentration of lead in blood, serum, cerebrospinal fluid, and urine was measured in patients with neurological disease and in control subjects including cases In 1925 Aub et al reported that 80% of the lead in blood resided in the plasma.' Their method of assay, titration, was elaborate, used many potentially contaminating. reagents, and was soon replaced by the colorimetric agent dithizone, which showed that most of the lead in blood was in fact bound to the red cells. Disagreement persisted into the 1940s, however, about the precise value for the partitioning, and not until the late 1950s was it firmly established that at least 90% of the lead in blood was red cell bound. The exact concentration of lead.in the plasma was below the detection limit of careful workers using dithizone. Both Willoughby and Wilkins2 and Robinson et a13 stated that it was undetectable, below 10 ,tg/dl (0-5 umoVI/). The modern instrumental technique of atomic absorption spectrophotometry has the required sensitivity, and several workers have reported plasma lead concentrations.4-There is general agreement that for the normal range of blood lead concentrations, [10][11][12][13][14][15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] ,ug/dl (0-5-1-2 ,umoll1) plasma lead ranges from 0-3 to 1 ,udl (15-50 nmoil).
In 1925 Aub et al reported that 80% of the lead in blood resided in the plasma. ' Their method of assay, titration, was elaborate, used many potentially contaminating. reagents, and was soon replaced by the colorimetric agent dithizone, which showed that most of the lead in blood was in fact bound to the red cells. Disagreement persisted into the 1940s, however, about the precise value for the partitioning, and not until the late 1950s was it firmly established that at least 90% of the lead in blood was red cell bound. The exact concentration of lead.in the plasma was below the detection limit of careful workers using dithizone. Both Willoughby and Wilkins2 and Robinson et a13 stated that it was undetectable, below 10 ,tg/dl (0-5 umoVI/). The modern instrumental technique of atomic absorption spectrophotometry has the required sensitivity, and several workers have reported plasma lead concentrations.4-There is general agreement that for the normal range of blood lead concentrations, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] ,ug/dl (0-5-1-2 ,umoll1) plasma lead ranges from 0-3 to 1 ,udl (15-50 nmoil).
The concentration of lead in the plasma has generally been cautiously reported, because a careful worker knew that the figure could not exceed the difference between that in whole blood and packed Received 25 500 ,ug/dl (24 , umoVl) in cases of lead intoxication.8 Their contemporaries, Cantarow and Trumper, reported much the same values.9 In 1952, in a careful study using dithizone, Butler was unable to reproduce the excessively high values reported in lead intoxication, but in patients with neurological disease he found 1-32 ,ug/dl (0.05-1-5 ,umol/l). ' °T his range appears to be confirmed by the modern worker using atomic absorption spectrophotometry, Samples were obtained at the convenience of the attending physician, and the question arose regarding the effect of diurnal or longer term fluctuations on the scatter of the results. To answer this, we measured the serum lead at intervals from several control subjects. One of these undertook a series of 36 hour fasts, enabling us to investigate the effect of prandial lead on the concentration of lead in the plasma. A similar question arose regarding the equilibration of lead between cerebrospinal fluid and plasma and its effect on the ratio of cerebrospinal fluid lead to plasma lead. Two patients undergoing chelation therapy provided a partial answer.
PATIENTS
The 36 patients taking part in this study were either followed up at the Dallas Veterans' Medical Center or the University of Texas Health Science Center at Dallas. Twenty five patients had other neurological disease or symptoms not involving heavy metal intoxication or motor neurone disease. The history, physical examination, and laboratory studies of the 11 patients diagnosed with motor neurone disease all meet the criteria outlined by Rowland20 for the diagnosis of motor neurone disease. Two cases were confirmed at necropsy. Informed consent was obtained from all subjects used in this study.
ANALYTICAL METHODS
Thirty millilitres of blood were drawn using an 18 gauge needle and a polypropylene syringe. Five ml were expelled into a 100 ml Teflon FEP bottle and the remainder into a Pyrex centrifuge tube. After retraction of the clot the blood was centrifuged and the serum transferred with a clean polypropylene pipette to a similar Teflon bottle. Approximately 10 ml of cerebrospinal fluid was allowed to drip from the needle hub into a Teflon bottle. Twenty four hour urines were collected in acid washed polyethylene jugs and a 10% aliquot was transferred to a 500 ml Teflon bottle. The tracer, 99-98% pure 206Pb, was added to each sample before being decomposed by boiling in 70% nitric acid. Lead was separated from blood and urine by coprecipitation with barium nitrate followed by electrodeposition, and from serum and cerebrospinal fluid by ion exchange. These techniques and those for tin are described elsewhere.'9 Isotope ratios were measured on a 30 cm radius, 600 sector field, single focusing mass spectrometer fitted with a Faraday cup collector.
Blanks were measured with each batch of five samples. Those associated with blood and urine measurements ranged from 1 to 2 ng Pb (0.05-0.1 nmol) and were negligible. To minimise the blank associated with serum and cerebrospinal fluid measurements, we gave the Teflon bottles, which we found had a memory, an additional cleaning by boiling double distilled nitric acid in them twice. The blank associated with the decomposition ranged from 0-5 to 0-8 ng (24-38 pmol) and that associated with the ion exchange column was reproducible at 0-3 ng (14 pmol).
A special problem was how to assess the blank associated with the collection of serum. In vitro, red cells rapidly bind radiolead suggesting that they might also scavenge any contaminating lead. We checked this by drawing two 30 ml blood samples from a subject and adding to one Pyrex tube 10 ng (0-5 nmol) of the weak x ray emmitter 205Pb. We identified by mass spectrometry only a trace of 205Pb in the serum and, what is more, obtained identical concentrations of lead in the two samples even though we had "contaminated" the one with about the same quantity of lead that it originally contained. This result led us to believe that in assays for lead in serum no extraordinary precautions have to be taken with regard to needles and syringes or the vessels used for clotting.
We found that cerebrospinal dripped through a metal stopcock (brass, with soldered luer connections) contained 100 times more lead than cerebrospinal dripped through the needle alone. Our At a blood lead concentration of 10 /ig/dl (0) (1) (2) (3) (4) (5) ,umol/l) serum lead is 0-25 gg/dl (12 nmol/l) and then rises as a steep function of blood lead concentration. Several subjects with blood lead concentrations below 20 ,ug/dl (1 ,umol/l) had serum lead con-316 Manton and Cook '' that corresponded closest to man with typical blood lead concentrations was one in which dogs were administered 203Pb in an infusion of 2 5 ,tg (0-12 ,mol) carrier lead per kg/min.'7 After one hour the animals showed an increment in blood lead concentration of 1-25 ,mg/dl (60 nmol/1) above their endogenous blood lead concentration (which was not measured). In these animals 30% of the lead was ultrafilterable and 62% of the filtered lead was reabsorbed. Applied to the nominal human glomerular filtration rate of 125 ml/min these figures give a renal clearance of 14 mlmin, in the middle of our range of uncorrected values. Vander et al have also shown that the ultrafilterability and thus the renal clearance of lead decreases with the total amount of lead infused.'6 Accordingly, our findings that the cases of lead intoxication had among the lowest clearances is consistent with their results.
The good agreement between our clearances and those obtained with radiolead testify to the accuracy of our measurement of lead in serum. If we had obtained values similar to those reported by atomic absorption our clearances would have been on average five times smaller or around 3 ml a minute. A value similar to the 0-002 ,ugldl (0- The relation between lead in serum and whole blood is similar to the curves reported for free erythrocyte porphyrin (FEP) in blood25 and 8-aminolaevulinic acid (8-ALA) in urine26 insofar as all show little change between blood lead concentrations of 10 and 40 ,ug Pb/dl (0-5-2 ,umol/l) but rise steeply thereafter. This result is not unexpected if the toxicity of lead is exerted by the moiety present in plasma. Hitherto the flat portions of the blood FEP and urinary 8-ALA curves have been attributed to instrumental insensitivity or to the presence of a constant background of these substances in blood. On the basis of our measurements we suggest that both are, in fact, accurately measuring the quantity of lead in the plasma of individuals eating ad libitum. We take our observation that the highest fractions of lead in cerebrospinal fluid with respect to serum were found in patients who had just undergone or were undergoing chelation therapy to imply that the equilibration between plasma and cerebrospinal fluid is slow, of the order of hours. Such slow equilibration would also account for the variability observed in the cerebrospinal fluid lead to serum lead fraction among the patients we had studied. O 
